Robert Funck - Abbott Laboratories Vice President Controller
| ABT Stock | MXN 2,360 56.20 2.33% |
President
Mr. Robert E. Funck is Vice President, Controller of Abbott Laboratories. Mr. Funck has served as the Companys Vice President, Chief Ethics and Compliance Officer since 2009, as Vice President, Internal Audit from 2007 to 2009, and as Vice President and Treasurer from 2005 to 2007. since 2013.
| Age | 62 |
| Tenure | 11 years |
| Phone | 224 667 6100 |
| Web | https://www.abbott.com |
Abbott Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.0882 % which means that it generated a profit of $0.0882 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1928 %, meaning that it generated $0.1928 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Rahul Samant | Delta Air Lines | 56 | |
| Andrew Iaboni | McEwen Mining | 41 | |
| Matthew Ellis | Verizon Communications | 52 | |
| Michael Bokan | Micron Technology | 62 | |
| April Arnzen | Micron Technology | 47 | |
| Robert Cardin | Martin Marietta Materials | 60 | |
| Michael Hartshorn | Ross Stores | 55 | |
| David Zinsner | Micron Technology | 49 | |
| Manish Bhatia | Micron Technology | 51 | |
| Paul Jacobson | Delta Air Lines | 47 | |
| John Mohr | Martin Marietta Materials | 58 | |
| Wayne West | Delta Air Lines | 58 | |
| James Nickolas | Martin Marietta Materials | 52 | |
| Peter Carter | Delta Air Lines | 59 | |
| Hans Vestberg | Verizon Communications | 58 | |
| Steven Sear | Delta Air Lines | 53 | |
| Joanne Smith | Delta Air Lines | 60 | |
| Joel Poppen | Micron Technology | 54 | |
| Brady Connor | Verizon Communications | N/A | |
| Brian Morrow | Ross Stores | 63 | |
| Scott DeBoer | Micron Technology | 57 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0882 |
Abbott Laboratories Leadership Team
Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Leinenweber, Licensing Relations | ||
| Robert Ford, Senior Vice President Diabetes Care. | ||
| James Young, VP Officer | ||
| Mary Moreland, Ex HR | ||
| Elaine Leavenworth, VP Officer | ||
| Robert Funck, Vice President Controller | ||
| Daniel Salvadori, Senior Vice President Established Pharmaceuticals, Latin America. | ||
| Andrea Wainer, Ex Diagnostics | ||
| Hubert Allen, Executive VP, General Counsel and Secretary | ||
| Melissa Brotz, VP Marketing |
Abbott Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abbott Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0882 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 3.99 T | |||
| Shares Outstanding | 1.74 B | |||
| Shares Owned By Insiders | 0.73 % | |||
| Shares Owned By Institutions | 75.70 % | |||
| Price To Book | 5.44 X | |||
| Price To Sales | 85.65 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.